ATE384714T1 - Pyrazolderivate - Google Patents

Pyrazolderivate

Info

Publication number
ATE384714T1
ATE384714T1 AT03799022T AT03799022T ATE384714T1 AT E384714 T1 ATE384714 T1 AT E384714T1 AT 03799022 T AT03799022 T AT 03799022T AT 03799022 T AT03799022 T AT 03799022T AT E384714 T1 ATE384714 T1 AT E384714T1
Authority
AT
Austria
Prior art keywords
compounds
preparation
reverse transcriptase
present
pyrazole derivatives
Prior art date
Application number
AT03799022T
Other languages
English (en)
Inventor
David Anthony Price
Matthew Duncan Selby
Paul Anthony Stupple
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE384714T1 publication Critical patent/ATE384714T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT03799022T 2002-10-07 2003-09-24 Pyrazolderivate ATE384714T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0223232.0A GB0223232D0 (en) 2002-10-07 2002-10-07 Chemical compounds

Publications (1)

Publication Number Publication Date
ATE384714T1 true ATE384714T1 (de) 2008-02-15

Family

ID=9945428

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03799022T ATE384714T1 (de) 2002-10-07 2003-09-24 Pyrazolderivate

Country Status (11)

Country Link
EP (1) EP1551828B1 (de)
JP (1) JP2006512299A (de)
AT (1) ATE384714T1 (de)
AU (1) AU2003263498A1 (de)
BR (1) BR0314860A (de)
CA (1) CA2501502A1 (de)
DE (1) DE60318874T2 (de)
ES (1) ES2298616T3 (de)
GB (1) GB0223232D0 (de)
MX (1) MXPA05002735A (de)
WO (1) WO2004031178A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200613272A (en) * 2004-08-13 2006-05-01 Astrazeneca Ab Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
US7868008B2 (en) 2005-08-12 2011-01-11 Astrazeneca Ab Substituted isoindolones and their use as metabotropic glutamate receptor potentiators
US7807706B2 (en) 2005-08-12 2010-10-05 Astrazeneca Ab Metabotropic glutamate-receptor-potentiating isoindolones
JP5031745B2 (ja) * 2005-08-12 2012-09-26 アストラゼネカ アクチボラグ 代謝型グルタミン酸受容体増強性イソインドロン
RU2451676C2 (ru) 2006-08-16 2012-05-27 Ф.Хоффманн-Ля Рош Аг Ненуклеозидные ингибиторы обратной транскриптазы
TWI417100B (zh) 2007-06-07 2013-12-01 Astrazeneca Ab 二唑衍生物及其作為代謝型麩胺酸受體增效劑-８４２之用途
JP2010530863A (ja) 2007-06-22 2010-09-16 エフ．ホフマン−ラ ロシュ アーゲー 非ヌクレオシド逆転写酵素阻害剤としての尿素及びカルバマート誘導体
WO2009080534A1 (en) 2007-12-21 2009-07-02 F. Hoffmann-La Roche Ag Heterocyclic antiviral compounds
DE102008015033A1 (de) * 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung
DE102008015032A1 (de) 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte Pyrazolamide und ihre Verwendung
US7790760B2 (en) 2008-06-06 2010-09-07 Astrazeneca Ab Metabotropic glutamate receptor isoxazole ligands and their use as potentiators 286
DE102008062878A1 (de) 2008-12-17 2010-06-24 Aicuris Gmbh & Co. Kg Substituierte Furancarboxamide und ihre Verwendung
DE102008062863A1 (de) 2008-12-17 2010-06-24 Aicuris Gmbh & Co. Kg Substituierte (Thiophenyl-carbonyl)imidazolidinone und ihre Verwendung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0016787D0 (en) * 2000-07-07 2000-08-30 Pfizer Ltd Compounds useful in therapy
GB0024795D0 (en) * 2000-10-10 2000-11-22 Hoffmann La Roche Pyrazole derivatives for the treatment of viral diseases
IL157875A0 (en) * 2001-04-10 2004-03-28 Pfizer Pyrazole derivatives for treating hiv

Also Published As

Publication number Publication date
JP2006512299A (ja) 2006-04-13
ES2298616T3 (es) 2008-05-16
CA2501502A1 (en) 2004-04-15
DE60318874T2 (de) 2009-01-22
EP1551828B1 (de) 2008-01-23
GB0223232D0 (en) 2002-11-13
EP1551828A1 (de) 2005-07-13
MXPA05002735A (es) 2005-05-23
BR0314860A (pt) 2005-08-02
DE60318874D1 (en) 2008-03-13
AU2003263498A1 (en) 2004-04-23
WO2004031178A1 (en) 2004-04-15

Similar Documents

Publication Publication Date Title
MY146669A (en) Pyrazole derivatives for treating hiv
EA200600225A1 (ru) Производные пиперазина для лечения вич инфекций
NO20044731L (no) Kinolin- og isokinolinderivater fremgangsmate for fremstilling derav og anvendelse derav som betennelseshemmere
CY1111693T1 (el) Αντιιικοι παραγοντες
DE60132309D1 (de) Amin-derivate zur behandlung von apoptosis
ATE372995T1 (de) Benzo(b)(1,4)dioxepinderivate
ATE384714T1 (de) Pyrazolderivate
NO20040881L (no) Orale antidiabetes midler.
BR0314759A (pt) Derivados de pirazol
NO983444D0 (no) Benzo(c)kinolizin derivater, deres fremstilling og anvendelse som 5<alfa>-reduktaseinhibitorer
BR0314709A (pt) Derivados de pirazol
GB0223234D0 (en) Chemical compounds
DK0944618T3 (da) Nye N-benzensulfonyl-L-prolin-derivater, fremgangsmåde til deres fremstilling og deres anvendelse til terapeutiske formål
EA200500287A1 (ru) Производные 4-(3, 5-дицианофенокси)пиразола для применения в качестве модуляторов обратной транскриптазы в лечении, в числе прочего, вич-инфекции
AP1846A (en) Pyrazole Derivatives.
WO2005100322A8 (en) Sulphur-linked imidazole compounds for the treament of hiv
ATE374775T1 (de) Inhibitoren des hiv-integrase-enzyms
HUP0402149A2 (hu) Vízoldható fenil-piridazin-származékok, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
DK1501823T3 (da) Hidtil ukendte piperidinyl-alkylamino-pyridazinon-derivater, en fremgangsmåde til fremstilling deraf og farmaceutiske præparater der indeholder forbindelserne
EA200800758A1 (ru) Ингибиторы фермента интегразы вич
DK1451184T3 (da) Dimere forbindelser og deres anvendelse som antivirale midler

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties